LONDON (UK) - Quanticate, a leading global data-focused clinical research organisation (CRO), has announced plans to expand its presence in North America with the opening of a new office in Toronto. The announcement comes as a result of continued success and a year of growth across it’s key strategic partnerships including expansion of work with a number of top five pharmaceutical companies.
Quanticate will deliver statistical consultancy, programming, data management, pharmacovigilance, and medical writing services to pharmaceutical, biotechnology, and medical device companies from the Toronto office and increases its existing footprint in North America.
Alan Morgan, Chief Operating officer at Quanticate added: “We are excited to announce our plans to establish an office in Toronto as it’s indicative of our continuing success, the growing demand for our services across the globe and the strong market position we hold as the clinical data experts.”
The company is relocating some key staff to the new office and also recruiting for a number of new roles based across biostatistics, programming and Data Management
By expanding its team, the company will also ensure it can meet the forecasted growth in demand across its clinical data services in the region over the coming years.
Morgan added: “By growing our presence in key markets such as North America we can continue to recruit top talent and deliver high quality data focused services to our growing customer base.”
The move into Toronto is the latest announcement from Quanticate following a recent new office opening in Mumbai and the expansion of its services in Hyderabad and Bangalore, India.